| URL | https://pharmaceutical-business-review.com/news/ag |
| Source | Pharmaceutical Business Review |
| Date Published | 08/19/2020 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Agilent |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2022 |
| Capital investment ($): | 150 |
| City reshored to: | Frederick |
| State(s) reshored to: | CO |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | nucleic acid-based therapeutics/ oligos |